Our Science – Stetler-Stevenson Website
William G. Stetler-Stevenson, M.D., Ph.D.
Selected Publications |
 |
| 1)
Han H, Bourboulia D, Jensen-Taubman S, Isaac B, Wei B, Stetler-Stevenson WG. An endogenous inhibitor of angiogenesis inversely correlates with side population phenotype and function in human lung cancer cells. Oncogene. [Epub ahead of print], 2013. [Journal] |
|
| 2)
Bourboulia D, Han H, Jensen-Taubman S, Gavil N, Isaac B, Wei B, Neckers L, Stetler-Stevenson WG. TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells. Oncotarget. 4: 163-73, 2013. [Journal] |
|
| 3)
Adamson A, Ghoreschi K, Rittler M, Chen Q, Sun HW, Vahedi G, Kanno Y, Stetler-Stevenson WG, O'Shea JJ, Laurence A. Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and th17 T-helper cell subsets and is a direct stat target gene. PLoS ONE. 8: e59367, 2013. [Journal] |
|
| 4)
Kim SH, Cho YR, Kim HJ, Oh JS, Ahn EK, Ko HJ, Hwang BJ, Lee SJ, Cho Y, Kim YK, Stetler-Stevenson WG, Seo DW. Antagonism of VEGF-A-induced increase in vascular permeability by an integrin a3ß1-Shp-1-cAMP/PKA pathway. Blood. 120: 4892-902, 2012. [Journal] |
|
| 5)
Stetler-Stevenson W, Bourboulia D, Guedex L, Jensen-Taubman S. Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development. Curr. Angiogenesis. 1: 148-56, 2012. [Journal] |
|
| 6)
Iwai A, Bourboulia D, Mollapour M, Jensen-Taubman S, Lee S, Donnelly AC, Yoshida S, Miyajima N, Tsutsumi S, Smith AK, Sun D, Wu X, Blagg BS, Trepel JB, Stetler-Stevenson WG, Neckers L. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells. Cell Cycle. 11: 3649-55, 2012. [Journal] |
|
| 7)
Gonçalves AN, Meschiari CA, Stetler-Stevenson WG, Nonato MC, Alves CP, Espreafico EM, Gerlach RF. Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli. J. Biotechnol. 157: 20-4, 2012. [Journal] |
|
| 8)
Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG. Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am. J. Pathol. 181: 1895-9, 2012. [Journal] |
|
| 9)
Bourboulia D, Jensen-Taubman S, Stetler-Stevenson W. TIMP-2 An Endogenous Angiogenesis Inhibitor with Distinct Antitumoral Properties. Treat. Strategies Hematol. 2: 31-35, 2012. [Journal] |
|
| 10)
Guedez L, Jensen-Taubman S, Bourboulia D, Kwityn CJ, Wei B, Caterina J, Stetler-Stevenson WG. TIMP-2 Targets Tumor-associated Myeloid Suppressor Cells With Effects in Cancer Immune Dysfunction and Angiogenesis. J. Immunother. 35: 502-12, 2012. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 5/1/2013.
